Webinar: Diabetic PN with Rodica Pop Busui, MD, PhD
Demystifying Diabetic Peripheral Neuropathy with Rodica Pop Busui, MD, PhD
Nerve damage caused by diabetes, a condition called diabetic peripheral neuropathy (DPN), is a common and debilitating complication that most often affects the extremities. Patients with diabetic peripheral neuropathy often develop painful symptoms which is known as painful diabetic peripheral neuropathy or diabetic nerve pain.
Diabetic nerve pain can be an extremely challenging condition to diagnose, treat and manage effectively, and the excruciating pain patients may experience has a significant impact on their quality of life.
This webinar is designed to help patients recognize key symptoms associated with diabetic nerve pain of the feet (achiness, throbbing, burning sensations, etc.) and serve as a foundation to help empower patients to speak with their healthcare providers – fostering more productive conversations around diagnosis, disease management and potential solutions for painful diabetic neuropathy.
The Foundation for Peripheral Neuropathy (FPN) is pleased to welcome Rodica Pop-Busui, MD, PhD, a prominent diabetologist at Michigan Medicine and a recognized leader in the field of diabetes and diabetes complications. Her research interests involve chronic complications of diabetes, particularly diabetic peripheral and cardiovascular autonomic neuropathy, as well as diabetic foot complications, diabetic kidney disease and cardiovascular disease, and the design and conduct of traditional and pragmatic clinical trials for patients with diabetes.
Webinar generously sponsored by Averitas Pharma and held live on Wednesday, September 7, 2022.
From Our Blog...
Diabetic peripheral neuropathy (DPN), or nerve damage caused by diabetes, is one of the most known causes of neuropathy. DPN can be a common complication
A study entitled “Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary” was published on December 29, 2021, in the journal Neurology®.
Recruiting for Study: An Evaluation of the Effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy Pain
Erchonia Corporation is currently recruiting for a study on the effect of Low Level Laser Therapy on Diabetic Peripheral Neuropathy pain. This study can be
Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy and Safety of NYX-2925 in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy.